News

Keep in touch

The latest 3Rs news and funding calls
NC3Rs news
Displaying 21 - 30 of 65

Twitter

Monday 18 July 2016
Current immunogenicity testing of drugs considers only the ‘antigenicity’ of the drug molecule, i.e. the ability of a compound to stimulate antibody production....
Wednesday 15 June 2016
There are two key areas in tumour biology that must be considered when developing models to study the disease – tumour heterogeneity and the tumour microenvironment...
Tuesday 14 June 2016
A paper reporting the development of a new automated home cage monitoring system for mice has been published this month in the journal Frontiers in Behavioural...
Wednesday 01 June 2016
Dr Davide D'Amico, Chief Executive Officer of ZeClinics provides his perspective on the impact of CRACK IT Solutions on the development and application of the...
Friday 20 May 2016
Work funded by the NC3Rs at the University of Sheffield has led to the development of a cell-based reporter assay that has the potential to replace thousands of...
Thursday 19 May 2016
Stemina Biomarker Discovery, Inc. has developed two reliable human stem cell-based assays for developmental toxicity screening. devTOX quickPredict rapidly...
Thursday 21 April 2016
Work funded by the NC3Rs at the University of Hull has led to the development of microfluidic devices capable of maintaining architecture, physiology and function...
Monday 18 April 2016
Biosystems Technologies Ltd. have developed TruLarvTM, research grade Galleria mellonella larvae for use in chemical and drug development pipelines as early screens...
Wednesday 23 March 2016
A new study has shown that introducing physiologic cues to the in vitro culture of hepatocyte-like cells (HLCs) makes them a more relevant hepatocyte model that can...
Wednesday 09 March 2016
Three projects have each been awarded £30,000 seed funding, through the NC3Rs CRACK IT Solutions partnering programme, to support collaborations which will help...
Subscribe to News